[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100636484":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":13,"studyPopulation":13,"armGroups":20,"interventions":27,"overallOfficials":13,"centralContacts":33,"locations":40,"responsibleParty":133,"collaborators":13,"id":135,"slug":13,"hasResults":136,"nctId":137,"briefTitle":138,"officialTitle":139,"acronym":13,"eligibilityCriteria":140,"healthyVolunteers":141,"sex":142,"minAge":143,"maxAge":13,"enrollmentInfo":144,"targetDuration":13,"studyType":147,"phases":148,"briefSummary":149,"conditions":150,"keywords":13,"overallStatus":152,"whyStopped":13,"lastUpdateSubmitDate":153,"lastUpdatePostDateStruct":154,"startDateStruct":157,"completionDateStruct":159,"leadSponsor":161,"locationsCount":162},{"fullName":5,"class":6},"Galderma R&D","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Number of Participants With Treatment-Emergent Adverse Events (TEAEs) Related to Device And\u002FOr Injection Procedure After the Month 12 Optional Retreatment","An adverse event (AE) is any untoward medical occurrence, unintended disease or injury, or untoward clinical signs (including abnormal laboratory findings) in participants, users or other persons, in the context of a clinical investigation, whether or not related to the investigational product (IP). TEAEs that are related to the device and\u002For injection procedure after the Month 12 optional retreatment will be reported.","From Month 12 up to 3 months after optional retreatment (i.e. Month 15)",null,{"allocation":15,"interventionModel":16,"interventionModelDescription":13,"primaryPurpose":17,"observationalModel":13,"timePerspective":13,"maskingInfo":18},"NA","SINGLE_GROUP","TREATMENT",{"masking":19,"maskingDescription":13,"whoMasked":13},"NONE",[21],{"label":22,"type":23,"description":24,"interventionNames":25},"Dermal Filler for Indication: Restylane Lyft with Lidocaine","EXPERIMENTAL","Participants will receive initial treatment with Restylane Lyft with Lidocaine in the chin region at Baseline with an optional touch-up treatment at 1 month after initial treatment and an optional retreatment 12 months after the last treatment.",[26],"Device: Restylane Lyft with Lidocaine",[28],{"type":29,"name":30,"description":31,"armGroupLabels":32,"otherNames":13},"DEVICE","Restylane Lyft with Lidocaine","Sterile gel of hyaluronic acid.",[22],[34],{"name":35,"role":36,"phone":37,"phoneExt":38,"email":39},"Clinical Project Manager","CONTACT","817-961-5000","+1","clinical.studies@galderma.com",[41,57,69,80,87,99,111,121],{"facility":42,"status":13,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Galderma Investigational Site # 8680","Westport","Connecticut","06880","United States","US",{"type":49,"coordinates":50},"Point",[51,52],-73.3579,41.14149,{"lat":52,"lon":51},[55],{"name":56,"role":36,"phone":13,"phoneExt":13,"email":13},"Galderma Project Manager",{"facility":58,"status":13,"city":59,"state":60,"zip":61,"country":46,"countryCode":47,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"Galderma Investigational Site # 8774","Boynton Beach","Florida","33437",{"type":49,"coordinates":63},[64,65],-80.06643,26.52535,{"lat":65,"lon":64},[68],{"name":56,"role":36,"phone":13,"phoneExt":13,"email":13},{"facility":70,"status":13,"city":71,"state":60,"zip":72,"country":46,"countryCode":47,"cosmosGeoPoint":73,"geoPoint":77,"contacts":78},"Galderma Investigational Site # 7030","Coral Gables","33134",{"type":49,"coordinates":74},[75,76],-80.26838,25.72149,{"lat":76,"lon":75},[79],{"name":56,"role":36,"phone":13,"phoneExt":13,"email":13},{"facility":81,"status":13,"city":71,"state":60,"zip":72,"country":46,"countryCode":47,"cosmosGeoPoint":82,"geoPoint":84,"contacts":85},"Galderma Investigational Site # 8682",{"type":49,"coordinates":83},[75,76],{"lat":76,"lon":75},[86],{"name":56,"role":36,"phone":13,"phoneExt":13,"email":13},{"facility":88,"status":13,"city":89,"state":90,"zip":91,"country":46,"countryCode":47,"cosmosGeoPoint":92,"geoPoint":96,"contacts":97},"Galderma Investigational Site # 7042","Atlanta","Georgia","30331",{"type":49,"coordinates":93},[94,95],-84.38798,33.749,{"lat":95,"lon":94},[98],{"name":56,"role":36,"phone":13,"phoneExt":13,"email":13},{"facility":100,"status":13,"city":101,"state":102,"zip":103,"country":46,"countryCode":47,"cosmosGeoPoint":104,"geoPoint":108,"contacts":109},"Galderma Investigational Site # 7043","Bethesda","Maryland","20852",{"type":49,"coordinates":105},[106,107],-77.10026,38.98067,{"lat":107,"lon":106},[110],{"name":56,"role":36,"phone":13,"phoneExt":13,"email":13},{"facility":112,"status":13,"city":113,"state":114,"zip":115,"country":46,"countryCode":47,"cosmosGeoPoint":116,"geoPoint":120,"contacts":13},"Galderma Investigational Site # 7118","Nashville","Tennessee","37203",{"type":49,"coordinates":117},[118,119],-86.78444,36.16589,{"lat":119,"lon":118},{"facility":122,"status":13,"city":123,"state":124,"zip":125,"country":46,"countryCode":47,"cosmosGeoPoint":126,"geoPoint":130,"contacts":131},"Galderma Investigational Site # 8662","Spring","Texas","77388",{"type":49,"coordinates":127},[128,129],-95.41716,30.07994,{"lat":129,"lon":128},[132],{"name":56,"role":36,"phone":13,"phoneExt":13,"email":13},{"type":134,"investigatorFullName":13,"investigatorTitle":13,"investigatorAffiliation":13,"oldNameTitle":13,"oldOrganization":13},"SPONSOR","100636484",false,"NCT07566286","Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region","A Prospective, Multicenter Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile","Inclusion Criteria:\n\n1. Males or non-pregnant, non-breastfeeding females, 22 years of age or older.\n2. Intent to receive treatment for augmentation and correction of retrusion in the chin region.\n\nExclusion Criteria:\n\n1. Known\u002Fprevious allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel or to gram positive bacterial proteins.\n2. Known\u002Fprevious allergy or hypersensitivity to local anesthetics, e.g. lidocaine or other amide-type anesthetics.\n3. Previous or present multiple allergies or severe allergies, such as manifested by anaphylaxis or angioedema, or family history of these conditions.\n4. Previous facial surgery (including facial aesthetic surgery and liposuction), below the level of the horizontal line from subnasale.\n5. Any previous aesthetic procedures or implants.\n6. Presence of any disease or lesions near or on the area to be treated.",true,"ALL","22 Years",{"count":145,"type":146},100,"ESTIMATED","INTERVENTIONAL",[15],"The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.",[151],"Chin Augmentation","NOT_YET_RECRUITING","2026-06-29",{"date":155,"type":156},"2026-07-01","ACTUAL",{"date":158,"type":146},"2026-06-03",{"date":160,"type":146},"2028-02-28",{"name":5,"class":6},8]